| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 25.05.
| Par Pharmaceutical - Ab heute wieder Rally? | | 2 | GodmodeTrader.de |
| 09.05.
| Par Pharma Beats on All Fronts | | 2 | Zacks |
| 09.05.
| Par Pharmaceutical Beats on Both Top and Bottom Lines | | - | Motley Fool |
| 08.05.
| UPDATE 1-Par Pharma 1st-qtr beats estimates | | - | Reuters.com |
| 08.05.
| Par Pharmaceutical Companies Reports First Quarter 2012 Results | | 20 | PR Newswire |
| WOODCLIFF LAKE, N.J., May 8, 2012 /PRNewswire/ --Par Pharmaceutical Companies, Inc. (NYSE: PRX) today reported results for the first quarter ended March 31, 2012.
For the first quarter ended March...
Mehr lesen zu:
Par Pharmaceutical Companies Reports First Quarter 2012 Results | |
| 01.05.
| Par Pharma CEO: Double Digit Growth | | - | The Street |
| 19.04.
| Par Pharmaceutical Acquires Rights to Market and Distribute Generic Dexilant® in the U.S. | | 19 | PR Newswire |
| WOODCLIFF LAKE, N.J., April 19, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that its Par Pharmaceutical, Inc. operating subsidiary has entered into an exclusive...
Mehr lesen zu:
Par Pharmaceutical Acquires Rights to Market and Distribute Generic Dexilant® in the U.S. | |
| 19.04.
| Par Pharmaceutical Acquires Rights to Market and Distribute Generic Dexilant® in the U.S. | | - | Benzinga.com |
| 09.04.
| Par Pharmaceutical Companies to Report First Quarter 2012 Results on May 8, 2012 | | 20 | PR Newswire |
| WOODCLIFF LAKE, N.J., April 9, 2012 /PRNewswire/ --Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced today that it will host a conference call and live webcast on Tuesday, May 8, 2012 at 9:00...
Mehr lesen zu:
Par Pharmaceutical Companies to Report First Quarter 2012 Results on May 8, 2012 | |
| 06.04.
| Par Pharma Begins Shipment Of Generic Provigil | | 144 | AFX News |
| PETAH TIKVA (dpa-AFX) - Par Pharmaceutical Companies, Inc. (PRX) on Friday
said it began shipping all strengths of modafinil tablets, a generic version of
Teva's Provigil brand. Par's initial...
Mehr lesen zu:
Par Pharma Begins Shipment Of Generic Provigil | |
| 06.04.
| Par Pharmaceutical Begins Shipment of Generic Provigil® | | 72 | PR Newswire |
| WOODCLIFF LAKE, N.J., April 6, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that it began shipping all strengths of modafinil tablets, a generic...
Mehr lesen zu:
Par Pharmaceutical Begins Shipment of Generic Provigil® | |
| 28.03.
| UPDATE 1-Horizon Pharma sues Par Pharma over arthritis drug patent | | 4 | Reuters.com |
| 28.03.
| Horizon Pharma Files Patent Infringement Lawsuit Against Par Pharmaceutical, Inc. for Filing an ANDA Against DUEXIS(R) | | 58 | MarketWire |
| DEERFIELD, IL -- (Marketwire) -- 03/28/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced it has filed a patent infringement lawsuit in the United States District Court for the District of...
Mehr lesen zu:
Horizon Pharma Files Patent Infringement Lawsuit Against Par Pharmaceutical, Inc. for Filing an ANDA Against DUEXIS(R) | |
| 28.03.
| Horizon Pharma (HZNP) Files Patent Infringement Suit Against Par Pharma (PRX) Over DUEXIS Tabs | | 3 | StreetInsider.com |
| 16.03.
| JP Morgan startet Par Pharma mit neutral. | | 37 | BörseGo |
| JP Morgan startet Par Pharma mit neutral.
(© BörseGo AG 2012 - Autor: Tobias Krieg, Redakteur)
Mehr lesen zu:
JP Morgan startet Par Pharma mit neutral. | |
| 28.02.
| UPDATE 1-Par Pharmaceutical 4th-qtr profit beats estimates | | 1 | Reuters.com |
| 28.02.
| Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2011 | | 38 | PR Newswire |
| WOODCLIFF LAKE, N.J., Feb. 28, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today reported results for the fourth quarter and full year ended December 31, 2011, which includes...
Mehr lesen zu:
Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2011 | |
| 17.02.
| Par Pharmaceutical Completes Acquisition of Edict Pharmaceuticals | | 111 | PR Newswire |
| WOODCLIFF LAKE, N.J., Feb.17, 2012 /PRNewswire/ --Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced today that it has completed the acquisition of privately-held Edict Pharmaceuticals Private...
Mehr lesen zu:
Par Pharmaceutical Completes Acquisition of Edict Pharmaceuticals | |
| 17.02.
| Horizon Pharma (HZNP) Says Par Pharma (PRX) Files ANDA for Generic DUEXIS | | 1 | StreetInsider.com |
| 06.02.
| Robbins Umeda LLP Announces an Investigation of Par Pharmaceutical Companies, Inc. | | 37 | Business Wire |
| Shareholder rights firm Robbins
Umeda LLP is investigating possible breaches of fiduciary duty and
other violations of the law by certain officers and directors at Par...
Mehr lesen zu:
Robbins Umeda LLP Announces an Investigation of Par Pharmaceutical Companies, Inc. | |
